Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Citius Oncology, Inc. - Common Stock (NQ:CTOR)

1.170 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Feb 18, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	1.170
Bid (Size)	1.140 (100)
Ask (Size)	1.260 (2,700)
Prev. Close	1.170
Today's Range	1.170 - 1.170
52wk Range	0.5506 - 6.190
Shares Outstanding	2,355,249
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Citius Oncology Transitions to Commercial Stage: Analyzing the 10-K Filing and the 2026 Outlook for LYMPHIR

December 23, 2025

CRANFORD, NJ — As the 2025 calendar year draws to a close, Citius Oncology, Inc. (Nasdaq: CTOR) has reached a pivotal juncture in its corporate evolution. Following the release of its SEC 10-K filing...

Via MarketMinute

Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations

December 04, 2025

Via Investor Brand Network

Performance

YTD	+8.3%	+8.3%
1 Month	+11.4%	+11.4%
3 Month	-3.3%	-3.3%
6 Month	-27.3%	-27.3%
1 Year	-0.8%	-0.8%

More News

Top stock movements in today's session. ↗

December 01, 2025

Via Chartmill

Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations

December 04, 2025

From BioMedWire

Via GlobeNewswire

Citius Oncology Launches Lymphir In US For Skin Cancer ↗

December 01, 2025

Via Stocktwits

12 Health Care Stocks Moving In Friday's After-Market Session ↗

September 19, 2025

Via Benzinga

Why Robinhood Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket ↗

September 08, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 02, 2025

Via Benzinga

Citius Oncology Beats Fiscal Q3 EPS ↗

August 12, 2025

Via The Motley Fool

Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators

August 06, 2025

Via Investor Brand Network

Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators

August 06, 2025

Via FinancialNewsMedia

Get insights into the top gainers and losers of Wednesday's pre-market session. ↗

July 16, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 16, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 15, 2025

Via Benzinga

Tuesday's after hours session: top gainers and losers ↗

July 15, 2025

Via Chartmill

These stocks are moving in today's session ↗

July 14, 2025

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 14, 2025

Via Benzinga

Which stocks are moving on Monday? ↗

July 14, 2025

Via Chartmill

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 10, 2025

Via Benzinga

Let's take a look at the stocks that are in motion in today's session. ↗

July 10, 2025

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 10, 2025

Via Benzinga

Which stocks are experiencing notable movement on Thursday? ↗

July 10, 2025

Via Chartmill

Mesoblast, Atai Life Sciences, Melco Resorts & Entertainment And Other Big Stocks Moving Higher On Tuesday ↗

July 01, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 27, 2025

Via Benzinga

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

June 27, 2025

Via Chartmill

Frequently Asked Questions

Is Citius Oncology, Inc. - Common Stock publicly traded?

Yes, Citius Oncology, Inc. - Common Stock is publicly traded.

What exchange does Citius Oncology, Inc. - Common Stock trade on?

Citius Oncology, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Citius Oncology, Inc. - Common Stock?

The ticker symbol for Citius Oncology, Inc. - Common Stock is CTOR on the Nasdaq Stock Market

What is the current price of Citius Oncology, Inc. - Common Stock?

The current price of Citius Oncology, Inc. - Common Stock is 1.170

When was Citius Oncology, Inc. - Common Stock last traded?

The last trade of Citius Oncology, Inc. - Common Stock was at 02/18/26 04:00 PM ET

What is the market capitalization of Citius Oncology, Inc. - Common Stock?

The market capitalization of Citius Oncology, Inc. - Common Stock is 2.76M

How many shares of Citius Oncology, Inc. - Common Stock are outstanding?

Citius Oncology, Inc. - Common Stock has 3M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.